Close Menu

Takara Bio

Eppendorf said this week that it has licensed patents covering gradient technology for thermal cyclers to Takara Bio.

Takara Bio has been awarded US Patent No. 8,048,987, "Polypeptides having DNA polymerase activity."
Yoshimi Sato, Kazue Nishiwaki, Nana Shimada, Shigekazu Hokazono, Takashi Uemori, Hiroyuki Mukai, and Ikunoshin Kato are named as inventors on the patent.

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

A US district court has dismissed a lawsuit filed earlier this year against more than a dozen life science companies alleging that they falsely marked certain nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

WaferGen Biosystems this week reported a nearly 10-fold year-over-year decline in second-quarter revenues due to an "absence of sales" of its SmartChip real-time PCR platform.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.